News

  • ACLA Update on COVID-19 Testing Capacity

    June 27, 2020
    WASHINGTON, D.C – Following a surge of new COVID-19 cases in the United States, ACLA President Julie Khani issued the following statement: “ACLA member laboratories have seen a steady increase in the volume of COVID-19 test orders. While our members are collectively performing hundreds of thousands of tests each day, the anticipated demand for COVID-19 testing over the coming weeks will likely exceed members’Continue Reading »...
  • Stakeholder Letter Calling For Extension of Public Health Emergency Declaration

    June 25, 2020
    ...
  • ACLA Letter to HHS on Data Reporting

    June 25, 2020
    ...
  • ACLA Responds to New Tri-Agency Guidance, Calls on Federal Government to Address Newly-Created Coverage Gaps

    June 23, 2020
    WASHINGTON, D.C. – Following additional guidance released today from the Department of Labor, the Department of Treasury, and the Department of Health and Human Services regarding the coverage and payment requirements for testing in the Families First Coronavirus Response Act and the CARES Act, ACLA President Julie Khani released the following statement: “As leading government officials outlined in congressional testimony today, testing is aContinue Reading »...
  • ACLA Letter to CDC on Antibody Guidance

    June 15, 2020
    ...
  • Amid Growing Demand For Testing, Lawmakers Call On HHS To Designate Resources For Clinical Laboratories

    June 08, 2020
     In a bipartisan letter to Secretary Azar, 30 lawmakers urge HHS to designate funds to help clinical laboratories expand capacity WASHINGTON, D.C. – As clinical laboratories continue to work around the clock to expand access to high-quality testing across the country, a bipartisan group of lawmakers today urged Health and Human Services Secretary Alex Azar to direct funds from the Public Health and SocialContinue Reading »...
  • ACLA Statement on New Data Reporting Guidance

    June 04, 2020
    WASHINGTON, D.C. – As ACLA reviews the new data reporting guidance released today by the Department of Health and Human Services (HHS), ACLA President Julie Khani released the following statement:   “Information is power. This simple truth drives our mission and purpose as clinical laboratories, and it’s why, since the start of this public health emergency, ACLA members have made every effort to report theContinue Reading »...
  • COVID-19 Frequently Asked Questions

    May 29, 2020
    Last Updated July 5, 2020 What is molecular PCR testing and when is it used? Molecular testing is the gold standard of diagnostic testing for COVID-19. This highly accurate testing method uses “PCR” (polymerase chain reaction) to detect the presence of a virus. For COVID-19 testing, this method typically uses upper and lower respiratory specimens. Molecular testing was the first kind of testing for COVID-19Continue Reading »...
  • ACLA Statement on Medicare Reimbursement Rate For Serologic Testing

    May 19, 2020
    WASHINGTON, D.C. – Following the release by the Centers for Medicare and Medicaid Services (CMS) of a reimbursement rate of $42.13 for the most commonly-performed COVID-19 serologic tests, ACLA President Julie Khani released the following statement: “We applaud CMS’ release of a Medicare reimbursement rate that will encourage a broad cross section of laboratories to rapidly scale up capacity for accurate and reliable serologicContinue Reading »...
  • ACLA Statement on HEROES Act

    May 12, 2020
    WASHINGTON, D.C. — Following the introduction of the ‘‘Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act” ACLA President Julie Khani issued the following statement: “ACLA is currently reviewing the HEROES Act. As noted in our letter to Secretary Azar last month, direct federal funding for laboratories performing COVID-19 testing is critical to achieve our nation’s testing goals. As labs across the country plan for the large capital expensesContinue Reading »...